NKTR
Nektar Therapeutics · Healthcare
Chief R, D Officer Jonathan Zalevsky sold $63K of Nektar Therapeutics
Sold$62,802
$54.28Price
1,157Shares
−6%Stake
What NKTR did after the filing
- The stock from Tue, Nov 25 close, $60.35
- −34.2%
- S&P 500, same days
- +3.7%
Measured over 30 trading days, to the Jan 9 close.
Traded Tue, Nov 25. Filed Tue, Nov 25, 3:30 PM ET, during the session. Returns use the Nov 25 close and the Jan 9 close. Not investment advice.